Short answer
Fulcrum Therapeutics, Inc. (FULC) filed an 8-K current report with the SEC on June 25, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected Sonja Banks, Alan Ezekowitz, and Colin Hill to three-year Class I director terms ending in 2029.
Fulcrum Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected Sonja Banks, Alan Ezekowitz, and Colin Hill to three-year Class I director terms ending in 2029
- Sonja Banks received 43,187,717 votes for and 10,601,385 withheld, signaling comparatively weaker support
- Executive compensation approved on an advisory basis, with 50,735,617 votes for versus 3,026,397 against
- Ernst & Young LLP ratified as independent auditor for fiscal 2026, with 58,793,645 votes for and 36,178 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Fulcrum Therapeutics, Inc. 8-K filings
Get the next FULC 8-K as it lands
Follow FULC for push alerts, or ask the research agent what this filing means.